瘤原和微环境信号驱动青少年骨髓单细胞白血病中细胞类型特异性亡耐药性
Naile Koleci1,2,3,4, Ying Wu1,2, Niels Anton Wehner1
1Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Cell death & disease
|March 8, 2025
概括
青少年骨髓单细胞白血病 (JMML) 涉及RAS通路的激活,影响细胞存活. 准BCL-XL对髓状细胞死亡有希望,但不能完全解决体内细胞的增殖.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 青少年骨髓单细胞白血病 (JMML) 是由RAS通路激活驱动的,导致血液细胞的增殖.
- 在JMML中RAS信号失调会影响细胞亡,影响癌细胞存活率.
研究的目的:
- 调查RAS通路激活如何影响JMML中的亡信号.
- 确定参与JMML细胞存活的关键BCL-2家族成员.
- 评估针对JMML中亡途径的治疗策略.
主要方法:
- 使用了模仿人类JMML的MxCre;Ptpn11D61Y/+小鼠模型.
- 分析了BCL-2家族成员的细胞类型特定调节.
- 在单细胞,粒细胞和干细胞/原生细胞中评估了亡耐药性.
- 评估了BCL-XL抑制功效在体外和体内.
主要成果:
- 通过对BCL-2家族成员的差异调节,RAS激活会改变亡.
- 单细胞和颗粒细胞通过BCL-XL/MCL-1过度表达和亲细胞亡下调表现出亡耐药性.
- BCL-XL和BCL-2对单细胞存活至关重要;MCL-1对中性粒细胞存活至关重要.
- 带有PTPN11突变的干细胞和原生细胞没有增加细胞灭亡抵抗力.
- 在体外,BCL-XL抑制有效地杀死髓状细胞,但在体内未能完全消除骨髓增殖.
结论:
- 由RAS驱动的JMML涉及复杂的细胞类型特定的细胞亡调节.
- 针对BCL-XL等抗亡的BCL-2家族成员,为JMML提供了一个潜在的治疗途径.
- 需要进一步的策略来克服耐药性并完全解决与JMML相关的骨髓增殖.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


